Galcanezumab-gnlm

Emgality® is a medication used to prevent migraine attacks. It belongs to a group of medications called Calcitonin Gene-Related Peptide (CGRP) Antagonists. It works by blocking a key migraine trigger before it can cause pain transmission and inflammation to initiate a migraine attack. Since it is injected on a consistent, monthly schedule, this protection stays in place 24/7 to continuously lower the frequency of migraines.

Be sure to discuss your medical history, current medications, and any concerns with your provider so they can determine whether Emgality® is right for you. Tell your provider if you have a high blood pressure or circulation problems in your fingers and toes. Let your provider know if you are pregnant, plan to become pregnant, or are breastfeeding.

The most common side effects of Emgality® are injection site reactions. More serious side effects include allergic reactions, high blood pressure, and Raynaud’s phenomenon. If you experience severe side effects, please seek immediate in-person medical care.

It's important to tell your provider if you are taking any other medications, over-the-counter drugs, supplements, or if you have any allergies. If you start using any new medications while taking metoclopramide, let your provider know. Check with your provider before stopping or starting any of your current medicines.

Emgality® is a once-monthly injection that you can administer at home following the instructions from your provider. Emgality® comes in an easy-to-use autoinjector pen.